A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).

被引：0

作者：

Hendifar, Andrew Eugene

Kim, Sungjin

Tighiouart, Mourad

Hautamaki, Emily

Kim, Haesoo

Ng, Camille

Liu, Jar-Yee

Scher, Kevin S.

Klempner, Samuel J.

Placencio-Hickok, Veronica

Gresham, Gillian

Gong, Jun

机构：

[1] Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA

[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[3] Cedars Sinai Med Ctr, West Hollywood, CA USA

[4] Tower Hematol Oncol Med Grp, Beverly Hills, CA USA

[5] Angeles Clin & Res Inst, Los Angeles, CA USA

[6] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4634

引用

页数：2